Recently, we have seen exciting developments in the antibody-drug conjugate (ADC) space, from cloud computing to radioisotopes.

Antibody-drug conjugates (ADCs) represent a promising approach in oncology due to their ability to deliver cytotoxic drugs selectively to cancer cells. By combining the tumor-targeting specificity of monoclonal antibodies (mAbs) with the potency of cytotoxic agents, ADCs are engineered to improve therapeutic outcomes while minimizing damage to healthy tissue. However, their therapeutic efficacy is not only dependent on the specific antibody or drug payload but also on a critical parameter known as the drug–antibody ratio (DAR).

The 15th Annual World Bispecifics Summit 2024 was held in Boston, MA on September 3-5, 2024. The event brought together experts in the field of bi, tri and multi-specifics, in addition to bispecific ADCs and BiTEs.

Discover how phage display technology is transforming biotechnology with high-throughput screening for antibodies, peptides, and therapeutic proteins.

Learn about dilution buffers in antibody research, their composition, & applications in ELISA, Western blotting, & immunohistochemistry for reliable results.

The 12th Immuno-Oncology Summit 2024 was held in Philadelphia, PA on August 7-9, 2024. The annual event serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology.

BIOPLUS-INTERPHEX KOREA 2024 was held in Seoul, Korea on July 10-12, 2024. The bio-pharmaceutical exhibition had keynote sessions, over 30 conferences, partnering, open innovation, and networking opportunities to expand overseas by building global business networks. → Biointron’s Highlighted

The 20th Annual PEGS Boston Summit 2024 was held in Boston, MA from May 13-17. During the event, industry experts from across the world gathered to share the latest research in advancements in drug development, protein and antibody engineering, immunotherapy, immunogenicity, expression platforms, mu

Learn how antibodies neutralize pathogens, aid in vaccine development, & enhance immune responses through opsonization. Explore their vital role in human health.

The 4th Fc-Mediated Function Summit 2024 was held in Boston, MA from April 17-18, and focused on discussions supercharging FcRn, FcγR, and IgG to advance molecular development, clinical utility, and novel therapeutic applications.

Explore ADCs in antibody research, combining monoclonal antibodies with cytotoxic drugs for precise cancer targeting. Learn their history, design, and benefits.

​The AACR Annual Meeting 2024 was held in San Diego, CA from April 5-10, and featured the latest advancements in cancer research, with hundreds of poster presentations, lectures, and exhibits. Scientists, health care professionals, and industry experts from around the world gathered to share innovations and trends in oncology, including: Advances in Diagnostics and Therapeutics...

Discover Fab, F(ab')2, and Fc antibody fragments—how they are formed, their functions in targeting antigens, and their evolution in research and therapy.

Biologics 2024 was held in London, UK, from March 13-15, and featured key opinion leaders, experts, and researchers in pharmaceuticals and biotech as well as academia. The event showcased the latest innovations and technological advancements in biologics discovery and development.The latest innovati

Discover the evolution, advantages, and diagnostic applications of single-chain variable fragments (scFvs) in antibody research. Learn about scFv production systems.